Physician profile
Robert M Sage
NPI 1871523316
$4,109.40
in general payments reported to CMS, 2019-2025
22 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2021: $31.32 · 2022: $661 · 2023: $852 · 2024: $1,037 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,398 · Travel and Lodging: $521 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,397.67 |
| Travel and Lodging | $521.32 |
| Education | $116.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,205.97 | 2019-2025 | Puraply, Affinity, Apligraf |
| Smith+Nephew, INC. | $1,016.87 | 2019-2025 | Grafix Pl, Oasis, Stravix Pl |
| Arthrex, INC. | $477.30 | 2024 | |
| Treace Medical Concepts, INC. | $412.59 | 2022-2025 | |
| Integra Lifesciences Corporation | $243.43 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $118.28 | 2025 | V.A.C. Veraflo, V.A.C.Ulta |
| Kerecis Limited | $116.83 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Heron Therapeutics, INC. | $79.84 | 2023 | Zynrelef |
| Linvatec Corporation | $78.99 | 2025 | Biobrace 23mm, Neospan |
| Stryker Corporation | $74.71 | 2022 | |
| Mimedx Group, INC. | $35.99 | 2024 | |
| Urgo Medical North America, LLC | $32.16 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Flower Orthopedics Coporation | $31.04 | 2025 | |
| Bioventus LLC | $30.00 | 2025 | Exogen Ultrasound Bone Healing System |
| Merck Sharp & Dohme LLC | $29.15 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $25.39 | 2023 | Amvuttra |
| Orthofix Medical, INC. | $20.16 | 2024 | Physio-Stim |
| Medline Industries LP | $19.65 | 2025 | |
| Acell, INC. | $17.58 | 2019 | |
| Tactile Systems Technology INC | $15.72 | 2024 | Flexitouch Plus, Entre Plus |
| Celularity INC. | $14.00 | 2019 | |
| Sanara Medtech INC. | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.